Netromycine 50mg/2ml (Paediatric) Injection
Netilmicin (as sulphate)
25mg/ml
Schering-Plough Labo N.V.
| Pack size | 2ml Vial |
|---|---|
| Dispensing mode | POM |
| Source | BELGIUM |
| Agent | CITY MEDICAL STORE |
| Retail Price | 14.50 AED |
Available as:
Indications
Netromycine 50mg/2ml (Paediatric) Injection is used for:
For the treatment of bacteremia, septicaemia, respiratory tract infections, skin and soft-tissue infection, burns, wounds, and peri-operative infections caused by susceptible strains.
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Netilmicin (as sulphate) :
Mechanism of Action
Aminoglycosides like netilmicin "irreversibly" bind to specific 30S-subunit proteins and 16S rRNA. Specifically netilmicin binds to four nucleotides of 16S rRNA and a single amino acid of protein S12. This interferes with decoding site in the vicinity of nucleotide 1400 in 16S rRNA of 30S subunit. This region interacts with the wobble base in the anticodon of tRNA. This leads to interference with the initiation complex, misreading of mRNA so incorrect amino acids are inserted into the polypeptide leading to nonfunctional or toxic peptides and the breakup of polysomes into nonfunctional monosomes, leaving the bacterium unable to synthesize proteins vital to its growth.
Note
Netromycine 50mg/2ml (Paediatric) 25mg/ml Injection manufactured by Schering-Plough Labo N.V.. Its generic name is Netilmicin (as sulphate). Netromycine 50mg/2ml (Paediatric) is availble in United Arab Emirates.
Farmaco UAE drug index information on Netromycine 50mg/2ml (Paediatric) Injection is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.